The Pistoia Alliance has appointed former PwC partner Steve Arlington as its new president.
Arlington was previously global lead partner of pharmaceuticals and life sciences consulting at PwC, a role he had held since 2006. Prior to this he held senior roles at Unipath and PA Consulting.
He said: “This is a very exciting time to be joining the Pistoia Alliance. The global healthcare and life sciences industries are undergoing huge changes, with regulators, payers, providers and patients all demanding more value.
“Today, there is a need for a marked departure from the traditional models, and technology and innovative applications of technology across the whole health, pharma and life sciences ecosystem will become more important than ever before.”
The non-profit alliance brings together life science companies, vendors, publishers and academic groups to work on lowering the barriers to innovation.
Its outgoing president Michael Braxenthaler said: “I am delighted to welcome Steve to the Pistoia Alliance. He has a wealth of experience in the life sciences sector, and this will be key to transforming how the sector operates. I am confident that under Steve’s leadership the Pistoia Alliance will continue to grow and demonstrate industry leadership.”